nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—MTNR1B—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0491	0.0588	CbGpPWpGaD
Agomelatine—MTNR1A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0491	0.0588	CbGpPWpGaD
Agomelatine—HTR2B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0372	0.0446	CbGpPWpGaD
Agomelatine—HTR2B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0313	0.0375	CbGpPWpGaD
Agomelatine—HTR2C—Monoamine GPCRs—CHRM3—nephrolithiasis	0.03	0.036	CbGpPWpGaD
Agomelatine—HTR2C—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0252	0.0303	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0223	0.0267	CbGpPWpGaD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0223	0.0267	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0191	0.0228	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0191	0.0228	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.0168	0.0201	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.0168	0.0201	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.0153	0.0183	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—RGS14—nephrolithiasis	0.0153	0.0183	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.0145	0.0174	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.0145	0.0174	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—PTH—nephrolithiasis	0.0133	0.0159	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—PTH—nephrolithiasis	0.0133	0.0159	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0129	0.0154	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0115	0.0138	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.0113	0.0136	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.0113	0.0136	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.0106	0.0127	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ADCY10—nephrolithiasis	0.0106	0.0127	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0104	0.0124	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.0103	0.0123	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—DGKH—nephrolithiasis	0.0103	0.0123	CbGpPWpGaD
Agomelatine—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00983	0.0593	CcSEcCtD
Agomelatine—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00964	0.0582	CcSEcCtD
Agomelatine—HTR2B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00929	0.0111	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00927	0.0111	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00927	0.0111	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—RGS14—nephrolithiasis	0.00901	0.0108	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—RGS14—nephrolithiasis	0.00901	0.0108	CbGpPWpGaD
Agomelatine—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00863	0.0521	CcSEcCtD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00831	0.00996	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0082	0.00983	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0082	0.00983	CbGpPWpGaD
Agomelatine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00785	0.0474	CcSEcCtD
Agomelatine—MTNR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.0075	0.00899	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—PTH—nephrolithiasis	0.0075	0.00899	CbGpPWpGaD
Agomelatine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0075	0.0453	CcSEcCtD
Agomelatine—HTR2C—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0075	0.00898	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00745	0.00893	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00745	0.00893	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00718	0.00861	CbGpPWpGaD
Agomelatine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00691	0.0417	CcSEcCtD
Agomelatine—MTNR1A—Signaling by GPCR—PTH—nephrolithiasis	0.00681	0.00817	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—PTH—nephrolithiasis	0.00681	0.00817	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00671	0.00804	CbGpPWpGaD
Agomelatine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00644	0.0389	CcSEcCtD
Agomelatine—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00635	0.00761	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00615	0.00738	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DGKH—nephrolithiasis	0.00609	0.0073	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DGKH—nephrolithiasis	0.00609	0.0073	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00609	0.0073	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00609	0.0073	CbGpPWpGaD
Agomelatine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00582	0.0351	CcSEcCtD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0058	0.00695	CbGpPWpGaD
Agomelatine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00567	0.0342	CcSEcCtD
Agomelatine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00563	0.034	CcSEcCtD
Agomelatine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00552	0.0334	CcSEcCtD
Agomelatine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00549	0.0332	CcSEcCtD
Agomelatine—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00542	0.0065	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00542	0.0065	CbGpPWpGaD
Agomelatine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0054	0.0326	CcSEcCtD
Agomelatine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0051	0.0308	CcSEcCtD
Agomelatine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00501	0.0302	CcSEcCtD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00496	0.00595	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—RGS14—nephrolithiasis	0.00492	0.0059	CbGpPWpGaD
Agomelatine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00474	0.0286	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00469	0.00562	CbGpPWpGaD
Agomelatine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00444	0.0268	CcSEcCtD
Agomelatine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00441	0.0266	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.0044	0.00527	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.0044	0.00527	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.00438	0.00524	CbGpPWpGaD
Agomelatine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00436	0.0263	CcSEcCtD
Agomelatine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00432	0.0261	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—PTH—nephrolithiasis	0.00429	0.00514	CbGpPWpGaD
Agomelatine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00423	0.0255	CcSEcCtD
Agomelatine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0042	0.0253	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—PTH—nephrolithiasis	0.00403	0.00482	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PTH—nephrolithiasis	0.00403	0.00482	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00401	0.0242	CcSEcCtD
Agomelatine—HTR2C—Signaling by GPCR—RGS14—nephrolithiasis	0.00397	0.00476	CbGpPWpGaD
Agomelatine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0039	0.0235	CcSEcCtD
Agomelatine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00388	0.0234	CcSEcCtD
Agomelatine—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.00378	0.00453	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.00366	0.00439	CbGpPWpGaD
Agomelatine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00352	0.0213	CcSEcCtD
Agomelatine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00347	0.021	CcSEcCtD
Agomelatine—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.00346	0.00414	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADCY10—nephrolithiasis	0.00342	0.0041	CbGpPWpGaD
Agomelatine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00336	0.0203	CcSEcCtD
Agomelatine—HTR2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00333	0.00399	CbGpPWpGaD
Agomelatine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00324	0.0196	CcSEcCtD
Agomelatine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00312	0.0188	CcSEcCtD
Agomelatine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00307	0.0186	CcSEcCtD
Agomelatine—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.00296	0.00354	CbGpPWpGaD
Agomelatine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00291	0.0176	CcSEcCtD
Agomelatine—HTR2B—Signaling Pathways—RGS14—nephrolithiasis	0.00291	0.00349	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.00276	0.00331	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.00268	0.00322	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00265	0.00317	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PTH—nephrolithiasis	0.00242	0.0029	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00241	0.00288	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	0.00235	0.00281	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	0.0022	0.00264	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00214	0.00256	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SPP1—nephrolithiasis	0.00202	0.00242	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SPP1—nephrolithiasis	0.00202	0.00242	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00197	0.00236	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	0.00197	0.00236	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	0.00195	0.00234	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.00194	0.00233	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	0.00177	0.00213	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00159	0.0019	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	0.00159	0.0019	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.00143	0.00172	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	0.00142	0.0017	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTH—nephrolithiasis	0.0013	0.00156	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.00128	0.00153	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.00122	0.00147	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	0.00115	0.00137	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.00109	0.00131	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.00109	0.0013	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APRT—nephrolithiasis	0.00109	0.0013	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTH—nephrolithiasis	0.00105	0.00126	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000928	0.00111	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000928	0.00111	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000774	0.000927	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.0007	0.000838	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.000661	0.000792	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	0.000652	0.000782	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CHRM3—nephrolithiasis	0.000598	0.000716	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	0.000526	0.000631	CbGpPWpGaD
